These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11927277)

  • 1. Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents.
    Nangia-Makker P; Conklin J; Hogan V; Raz A
    Trends Mol Med; 2002 Apr; 8(4):187-92. PubMed ID: 11927277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancer-associated carbohydrate-binding protein galectin-3 and its therapeutic ligands].
    Bai H; Liu L; Li YH; You Y; Mei QB
    Sheng Li Ke Xue Jin Zhan; 2008 Apr; 39(2):129-34. PubMed ID: 18664176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological modulation by lectins and their ligands in tumor progression and metastasis.
    Nakahara S; Raz A
    Anticancer Agents Med Chem; 2008 Jan; 8(1):22-36. PubMed ID: 18220503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular mechanism of sulfated carbohydrate recognition by the cysteine-rich domain of mannose receptor.
    Liu Y; Misulovin Z; Bjorkman PJ
    J Mol Biol; 2001 Jan; 305(3):481-90. PubMed ID: 11152606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of the galectin family of mammalian carbohydrate-binding proteins.
    Hughes RC
    Biochim Biophys Acta; 1999 Dec; 1473(1):172-85. PubMed ID: 10580137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vertebrate galectins: structure and function, role in tumoral process].
    Bassen R; Brichory F; Caulet-Maugendre S; Delaval P; Dazord L
    Bull Cancer; 2000 Oct; 87(10):703-7. PubMed ID: 11084533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
    André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
    J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity enhancement by multivalent lectin-carbohydrate interaction.
    Lee RT; Lee YC
    Glycoconj J; 2000; 17(7-9):543-51. PubMed ID: 11421347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian galectins: structure, carbohydrate specificity, and functions.
    Rapoport EM; Kurmyshkina OV; Bovin NV
    Biochemistry (Mosc); 2008 Apr; 73(4):393-405. PubMed ID: 18457568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis.
    Gorelik E; Galili U; Raz A
    Cancer Metastasis Rev; 2001; 20(3-4):245-77. PubMed ID: 12085965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate recognition in neuronal development: structure and expression of surface oligosaccharides and beta-galactoside-binding lectins.
    Hynes MA; Buck LB; Gitt M; Barondes S; Dodd J; Jessell TM
    Ciba Found Symp; 1989; 145():189-210; discussion 210-8. PubMed ID: 2791751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of carbohydrate-binding preferences of human galectins with carbohydrate microarrays.
    Horlacher T; Oberli MA; Werz DB; Kröck L; Bufali S; Mishra R; Sobek J; Simons K; Hirashima M; Niki T; Seeberger PH
    Chembiochem; 2010 Jul; 11(11):1563-73. PubMed ID: 20572248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor metastases and adhesion molecules carbohydrates and lectins].
    Nemoto Y; Irimura T
    Gan To Kagaku Ryoho; 1999 May; 26(6):849-56. PubMed ID: 10410158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of hydroxylysine-linked saccharides by galaptin, a galactoside-binding animal tissue lectin.
    Ahmed H; Allen HJ; DiCioccio RA
    Carbohydr Res; 1991 Jun; 213():321-4. PubMed ID: 1933946
    [No Abstract]   [Full Text] [Related]  

  • 15. Discovery and design of carbohydrate-based therapeutics.
    Cipolla L; Araújo AC; Bini D; Gabrielli L; Russo L; Shaikh N
    Expert Opin Drug Discov; 2010 Aug; 5(8):721-37. PubMed ID: 22827796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding and cross-linking properties of galectins.
    Fred Brewer C
    Biochim Biophys Acta; 2002 Sep; 1572(2-3):255-62. PubMed ID: 12223273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles of carbohydrates and glycomimetics in anticancer drug design.
    Barchi JJ
    Curr Pharm Des; 2000 Mar; 6(4):485-501. PubMed ID: 10788593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate recognition using metal-ligand assemblies.
    Ahamed R; Venkatesh J; Srithar R; Gaikwad S; Pramanik S
    Org Biomol Chem; 2023 Jul; 21(27):5492-5505. PubMed ID: 37255418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A guide to the carbohydrate specificities of applied lectins-2 (updated in 2000).
    Wu AM; Song SC; Tsai MS; Herp A
    Adv Exp Med Biol; 2001; 491():551-85. PubMed ID: 14533822
    [No Abstract]   [Full Text] [Related]  

  • 20. Lectin-mediated drug targeting: selection of valency, sugar type (Gal/Lac), and spacer length for cluster glycosides as parameters to distinguish ligand binding to C-type asialoglycoprotein receptors and galectins.
    André S; Frisch B; Kaltner H; Desouza DL; Schuber F; Gabius HJ
    Pharm Res; 2000 Aug; 17(8):985-90. PubMed ID: 11028946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.